3,5-dimethyl-4-[3-(1-methylpyrazol-4-yl)-1-(pyrimidin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-1,2-oxazole
C21H19N7O — CID 118059510
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3,5-dimethyl-4-[3-(1-methylpyrazol-4-yl)-1-(pyrimidin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-1,2-oxazole
3,5-dimethyl-4-[3-(1-methylpyrazol-4-yl)-1-(pyrimidin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-1,2-oxazole (PubChem CID 118059510) has the molecular formula C21H19N7O and a molecular weight of 385.43 g/mol. Its IUPAC name is 3,5-dimethyl-4-[3-(1-methylpyrazol-4-yl)-1-(pyrimidin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-1,2-oxazole.
Molecular Properties
| Compound Name | 3,5-dimethyl-4-[3-(1-methylpyrazol-4-yl)-1-(pyrimidin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-1,2-oxazole |
|---|---|
| PubChem CID | 118059510 |
| Molecular Formula | C21H19N7O |
| Molecular Weight | 385.43 g/mol |
| Exact Mass | 385.17 |
| IUPAC Name | 3,5-dimethyl-4-[3-(1-methylpyrazol-4-yl)-1-(pyrimidin-2-ylmethyl)pyrrolo[3,2-b]pyridin-6-yl]-1,2-oxazole |
| SMILES | Cc1noc(C)c1-c1cnc2c(-c3cnn(C)c3)cn(Cc3ncccn3)c2c1 |
| InChI | InChI=1S/C21H19N7O/c1-13-20(14(2)29-26-13)15-7-18-21(24-8-15)17(16-9-25-27(3)10-16)11-28(18)12-19-22-5-4-6-23-19/h4-11H,12H2,1-3H3 |
| InChIKey | XIHSSWODHBTEJB-UHFFFAOYSA-N |
| XLogP | 3.55 |
| TPSA | 87.45 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 385.43 |
| LogP ≤ 5 | 3.55 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'dyes5A(27)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118059510 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.